FEI to Delay New Medication Rules
The Fédération Equestre Internationale (FEI) Bureau has passed a resolution delaying implementation of the new Equine Prohibited Substances List and the accompanying Equine Anti-Doping and Controlled Medication Regulations until April 5, 2010.
The resolution was passed in order to allow for broader debate and consultation on the policy change approved at the
- Topics: Article
The Fédération Equestre Internationale (FEI) Bureau has passed a resolution delaying implementation of the new Equine Prohibited Substances List and the accompanying Equine Anti-Doping and Controlled Medication Regulations until April 5, 2010.
The resolution was passed in order to allow for broader debate and consultation on the policy change approved at the recent FEI General Assembly regarding the restricted use of a small number of non-steroidal anti-inflammatory drugs (NSAIDs). The decision, which reversed the 1993 ban on phenylbutazone, has provoked considerable debate among FEI stakeholders.
The FEI recognizes that a number of issues arise as a result of this policy change, which was voted in by a majority of 53-48 at the meeting in Copenhagen on Nov. 19.
The change in policy will affect National Federations and organizers who must comply with state laws as well as international competition rules. It has implications for the breeding industry and the selection of horses and might impact animal welfare concerns. It also affects the laboratories involved in the testing procedures
Create a free account with TheHorse.com to view this content.
TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.
Start your free account today!
Already have an account?
and continue reading.
Related Articles
Stay on top of the most recent Horse Health news with